Press Releases
Search
-
26 Feb 2015
BioFire Receives FDA Clearance for the FilmArray® 2.0 System
New system delivers higher throughput, single database management and minimized footprint Marcy l’Etoile, France – February 26, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, ...
-
10 Feb 2015
BioFire Defense, a bioMérieux Company, Receives Prestigious Frost & Sullivan’s 2014 Global New Product Innovation Award for its FilmArray® Ebola Test
BioFire Defense, LLC is proud to announce that it is the recipient of the Frost & Sullivan’s 2014 Global New Product Innovation Award for its FilmArray® Ebola test. The New Product Innovation Award is...
-
22 Jan 2015
bioMérieux and Astute Medical sign a global agreement to develop and market NephroCheck® Test for VIDAS®, an assay to assess the risk of developing acute kidney injury
Marcy l’Etoile, (France) - San Diego, California (United States) - January 22, 2015 - bioMérieux, a world leader in the field of in vitro diagnostics, and Astute Medical, Inc., a company dedicated to ...
-
22 Jan 2015
Business Review for the Three Months and Full Year Ended December 31, 2014
Sales: solid growth, lifted sharply by BioFire Revenue: €1,698 million, up a reported 7% Up 8.7%, including BioFire and at constant exchange rates Up 3.8% at constant exchange rates and scope of conso...
-
09 Jan 2015
Strategic alliance between bioMérieux and COPAN to automate clinical microbiology laboratories and enhance their operational efficiency
bioMérieux distributes COPAN’s WASP® and WASPLab™ automated systems and speeds up deployment of its “FMLA® - Lab Efficiency” vision »...
-
18 Nov 2014
bioMérieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections
Marcy l’Etoile, France – San Diego, California, United States – November 18, 2014 – bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina, a world leader in genomics, announced...
-
27 Oct 2014
BioFire Defense, a bioMérieux company, receives fast-track authorization of FilmArray® Ebola Test
Marcy l’Etoile (France) - October 27, 2014 - BioFire Defense, LLC of Salt Lake City, UT announced today that it has received Emergency Use Authorization by the U.S. Food and Drug Administration (FDA) ...
-
22 Oct 2014
Business Review for the Nine Months Ended September 30, 2014
Solid growth in nine-month sales: Up 7.4%, including BioFire and at constant exchange rates Up 3.5% at constant exchange rates and scope of consolidation, in line with the full-year target The America...
-
10 Oct 2014
bioMérieux inaugurates a new multidisciplinary R&D center for infectious disease diagnostics
The R&D Center at La Balme-Les-Grottes is specialized in the development of new diagnostic solutions in microbiology: high medical value tests for improved patient care and fully automated solutions t...
-
18 Sep 2014
bioMérieux launches chromID® Salmonella Elite, the new generation of culture media for earlier detection of Salmonella strains in clinical fecal samples
Marcy l'Étoile, France – September 18, 2014 – bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the launch of chromID® Salmonella Elite, a new selective chromogen...
-
03 Sep 2014
bioMérieux - First-Half 2014 Results
Solid growth in first-half sales Up 7.9%, including BioFire and at constant exchange rates Up 4.2% at constant exchange rates and scope of consolidation 2014 financial objectives maintained Contributi...
-
23 Jul 2014
bioMérieux VIRTUO™, the new generation of blood culture system, is CE-marked
VIRTUO™ is the next dimension of blood culture microbial detection...
-
17 Jul 2014
bioMérieux - Second-Quarter 2014 Business Review
Solid growth in first-half sales Up 7.9%, including BioFire and at constant exchange rates Up 4.2% like-for-like*, in line with the target for the year Up 3.5% on a reported basis Greater disparity be...
-
28 May 2014
The General Shareholders’ Meeting of bioMérieux approves the appointment of two new independent directors
Marcy l’Etoile, France, May 28, 2014 - The General Meeting of Shareholders of bioMérieux, a world leader in the field of in vitro diagnostics, today approved the appointment of two new independent dir...
-
05 May 2014
BioFire’s FilmArray® Gastrointestinal Panel Receives FDA Clearance
Marcy l’Etoile, France - May 5, 2014 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire, its new molecular biology affiliate, received U.S. Food and Drug A...